These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37775442)

  • 1. Standards for the care of people with cystic fibrosis (CF): A timely and accurate diagnosis.
    Castellani C; Simmonds NJ; Barben J; Addy C; Bevan A; Burgel PR; Drevinek P; Gartner S; Gramegna A; Lammertyn E; Landau EEC; Middleton PG; Plant BJ; Smyth AR; van Koningsbruggen-Rietschel S; Girodon E; Kashirskaya N; Munck A; Nährlich L; Raraigh K; Sermet-Gaudelus I; Sommerburg O; Southern KW
    J Cyst Fibros; 2023 Nov; 22(6):963-968. PubMed ID: 37775442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
    Barben J; Castellani C; Munck A; Davies JC; de Winter-de Groot KM; Gartner S; Kashirskaya N; Linnane B; Mayell SJ; McColley S; Ooi CY; Proesmans M; Ren CL; Salinas D; Sands D; Sermet-Gaudelus I; Sommerburg O; Southern KW;
    J Cyst Fibros; 2021 Sep; 20(5):810-819. PubMed ID: 33257262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres.
    Terlizzi V; Claut L; Tosco A; Colombo C; Raia V; Fabrizzi B; Lucarelli M; Angeloni A; Cimino G; Castaldo A; Marsiglio L; Timpano S; Cirilli N; Moroni L; Festini F; Piccinini P; Zavataro L; Bonomi P; Taccetti G; Southern KW; Padoan R
    J Cyst Fibros; 2021 Sep; 20(5):828-834. PubMed ID: 33883100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of CFTR-related disorders and cystic fibrosis in an Italian cohort of CRMS/CFSPID subjects in preschool and school age.
    Fevola C; Dolce D; Tosco A; Padoan R; Daccò V; Claut L; Schgor T; Sepe A; Timpano S; Fabrizzi B; Piccinini P; Taccetti G; Bonomi P; Terlizzi V
    Eur J Pediatr; 2024 Feb; 183(2):929-938. PubMed ID: 38054992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis.
    Ooi CY; Sutherland R; Castellani C; Keenan K; Boland M; Reisman J; Bjornson C; Chilvers MA; van Wylick R; Kent S; Price A; Mateos-Corral D; Hughes D; Solomon M; Zuberbuhler P; Brusky J; Durie PR; Ratjen F; Gonska T
    BMC Pediatr; 2019 Oct; 19(1):369. PubMed ID: 31640630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rates of anxiety detected in mothers of children with inconclusive cystic fibrosis screening results.
    Ginsburg DK; Salinas DB; Cosanella TM; Wee CP; Saeed MM; Keens TG; Gold JI
    J Cyst Fibros; 2023 May; 22(3):420-426. PubMed ID: 36528525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis.
    Ren CL; Borowitz DS; Gonska T; Howenstine MS; Levy H; Massie J; Milla C; Munck A; Southern KW
    J Pediatr; 2017 Feb; 181S():S45-S51.e1. PubMed ID: 28129812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of disease-causing CFTR variants in state newborn screening programs.
    McGarry ME; Ren CL; Wu R; Farrell PM; McColley SA
    Pediatr Pulmonol; 2023 Feb; 58(2):465-474. PubMed ID: 36237137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes.
    Kay DM; Sadeghi H; Kier C; Berdella M; DeCelie-Germana JK; Soultan ZN; Goetz DM; Caggana M; Fortner CN; Giusti R; Kaslovsky R; Stevens C; Voter K; Welter JJ; ; Langfelder-Schwind E
    Pediatr Pulmonol; 2024 Jul; 59(7):1952-1961. PubMed ID: 38695616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification.
    Salinas DB; Ginsburg DK; Wee CP; Saeed MM; Brewington JJ
    Pediatr Pulmonol; 2023 Apr; 58(4):1074-1084. PubMed ID: 36582049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians.
    Terlizzi V; Farrell PM
    Curr Probl Pediatr Adolesc Health Care; 2024 Jun; 54(6):101637. PubMed ID: 38811287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CFTR variant profile of Hispanic patients with cystic fibrosis: Impact on access to effective screening, diagnosis, and personalized medicine.
    Januska MN; Marx L; Walker PA; Berdella MN; Langfelder-Schwind E
    J Genet Couns; 2020 Aug; 29(4):607-615. PubMed ID: 32227567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.
    Pagin A; Sermet-Gaudelus I; Burgel PR
    Arch Pediatr; 2020 Feb; 27 Suppl 1():eS25-eS29. PubMed ID: 32172933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic challenges in CFTR-related metabolic syndrome: Where the guidelines fall short.
    Kallam EF; Kasi AS; Barr E; Linnemann RW; Guglani L
    Paediatr Respir Rev; 2024 Mar; 49():28-33. PubMed ID: 37659865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond.
    ; Borowitz D; Parad RB; Sharp JK; Sabadosa KA; Robinson KA; Rock MJ; Farrell PM; Sontag MK; Rosenfeld M; Davis SD; Marshall BC; Accurso FJ
    J Pediatr; 2009 Dec; 155(6 Suppl):S106-16. PubMed ID: 19914443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When CFSPID becomes CF.
    Ginsburg D; Wee CP; Reyes MC; Brewington JJ; Salinas DB
    J Cyst Fibros; 2022 Jan; 21(1):e23-e27. PubMed ID: 34756682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
    Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
    Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID).
    Sinha A; Southern KW
    Breathe (Sheff); 2021 Sep; 17(3):210088. PubMed ID: 35035555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis newborn screening: the importance of bloodspot sample quality.
    Doull I; Course CW; Hanks RE; Southern KW; Forton JT; Thia LP; Moat SJ
    Arch Dis Child; 2021 Mar; 106(3):253-257. PubMed ID: 32859613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn blood spot screening for cystic fibrosis with a four-step screening strategy in the Netherlands.
    Dankert-Roelse JE; Bouva MJ; Jakobs BS; Janssens HM; de Winter-de Groot KM; Schönbeck Y; Gille JJP; Gulmans VAM; Verschoof-Puite RK; Schielen PCJI; Verkerk PH
    J Cyst Fibros; 2019 Jan; 18(1):54-63. PubMed ID: 30146269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.